July 20, 2020 by IrishExaminer.com GSK throws €142m behind innovative vaccine developer CureVac British drug giant GlaxoSmithKline has backed a “cutting edge” player in the race to develop a vaccine for coronavirus.GSK said it was putting £130m ... From our friends over at the : IrishExaminer.com You can see the Full Story: Click Here